Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CORRECTION: Prestige Consumer Healthcare Raised 2024 Diluted EPS Guidance To Approximately $4.33 From Prior Guidance Of $4.27-$4.32 Versus Consensus Of $4.32

Author: Benzinga Newsdesk | February 08, 2024 12:43pm

Posted In: PBH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist